Overview Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD Status: Withdrawn Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary This study will evaluate the safety and preliminary effectiveness of PDS 1.0 in patients with neovascular AMD. Phase: Phase 1 Details Lead Sponsor: Forsight Vision4